Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease

por Duty, Susan
Publicado 2010

Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation

por Carbone, Marica, Duty, Susan, Rattray, Marcus
Publicado 2012

Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson’s disease

por Buhidma, Yazead, Hobbs, Carl, Malcangio, Marzia, Duty, Susan
Publicado 2023

Brain Morphometry and the Neurobiology of Levodopa-Induced Dyskinesias: Current Knowledge and Future Potential for Translational Pre-Clinical Neuroimaging Studies

por Finlay, Clare J., Duty, Susan, Vernon, Anthony C.
Publicado 2014

Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner

por Boshoff, Eugene.L., Fletcher, Edward.J.R., Duty, Susan
Publicado 2018

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease

por Buhidma, Yazead, Rukavina, Katarina, Chaudhuri, Kallol Ray, Duty, Susan
Publicado 2020

Medications as a source of human exposure to phthalates.

por Hauser, Russ, Duty, Susan, Godfrey-Bailey, Linda, Calafat, Antonia M
Publicado 2004

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease

por Fletcher, Edward J. R., Moon, Lawrence D. F., Duty, Susan
Publicado 2019

Drug repurposing strategies of relevance for Parkinson’s disease

por Fletcher, Edward J. R., Kaminski, Thomas, Williams, Gareth, Duty, Susan
Publicado 2021

Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research

por Lama, Joana, Buhidma, Yazead, Fletcher, Edward J.R., Duty, Susan
Publicado 2021

Personal Care Product Use Predicts Urinary Concentrations of Some Phthalate Monoesters

por Duty, Susan M., Ackerman, Robin M., Calafat, Antonia M., Hauser, Russ
Publicado 2005

Proinflammatory profile in the skin of Parkinson’s disease patients with and without pain

por Lama, Joana, Salabasidou, Elena, Volkmann, Jens, Kuzkina, Anastasia, Duty, Susan, Üçeyler, Nurcan
Publicado 2022

Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats

por Fletcher, Edward J. R., Jamieson, Aran D., Williams, Gareth, Doherty, Patrick, Duty, Susan
Publicado 2019

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats

por Fletcher, Edward J. R., Finlay, Clare J., Amor Lopez, Ana, Crum, William R., Vernon, Anthony C., Duty, Susan
Publicado 2020

The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay.

por Duty, Susan M, Singh, Narendra P, Silva, Manori J, Barr, Dana B, Brock, John W, Ryan, Louise, Herrick, Robert F, Christiani, David C, Hauser, Russ
Publicado 2003

A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson’s...

por Clarke, Emily, Stocki, Pawel, Sinclair, Elizabeth H., Gauhar, Aziz, Fletcher, Edward J. R., Krawczun-Rygmaczewska, Alicja, Duty, Susan, Walsh, Frank S., Doherty, Patrick, Rutkowski, Julia Lynn
Publicado 2022